Months 37 Cagrilintide Layered, Stack Titration Once retatrutide is stable, cagrilintide enters at 0.25 mg/week and follows the REDEFINE 1 4-week-per-step ramp
The diagnosis of NAFLD relies on imaging [1] and histology, which enables the distinction to be made between simple fatty liver and NASH, where lobular inflammation and ballooning degeneration are also present [2, 3]
Brand choices include Wegovy, Zepbound, Saxenda, Contrave, and Qsymia
Most are gastrointestinal, including nausea, vomiting, diarrhea, constipation, or abdominal discomfort, but some symptoms may signal dehydration, kidney stress, gallbladder disease, pancreatitis, hypoglycemia, or another problem that requires medical evaluation
It's important to note that semaglutide is not recommended for patients with severe gastroparesis, as it could potentially worsen this condition
If all documentation is complete, PA decisions typically come within 1-7 business days